Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer
暂无分享,去创建一个
Eisaku Ito | Kazutaka Saito | Kazunori Kihara | Noboru Numao | Yasuhisa Fujii | Fumitaka Koga | Yoh Matsuoka | Junichiro Ishioka | Soichiro Yoshida | Takayuki Nakayama | Hideki Takeshita | Hiroshi Nakajima | E. Ito | K. Kihara | T. Akashi | S. Yoshida | F. Koga | T. Kijima | J. Ishioka | Y. Matsuoka | Kazutaka Saito | Y. Fujii | N. Numao | Hiroshi Tanaka | Hideki Takeshita | Hiroshi Tanaka | H. Nakajima | Hyeyeol Bae | Miyako Oya | Takayuki Nakayama | Toshiki Kijima | Hyeyeol Bae | Miyako Oya | Takumi Akashi | K. Saito | H. Takeshita | T. Nakayama
[1] Y. Ishikawa,et al. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. , 2007, European urology.
[2] Mark Emberton,et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.
[3] P. Box. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer , 2011 .
[4] Jiani Hu,et al. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. , 2012, AJR. American journal of roentgenology.
[5] Toshihiro Kumabe,et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. , 2006, Radiology.
[6] Seung Hong Choi,et al. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. , 2011, Radiology.
[7] K. Kihara,et al. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. , 2011, AJR. American journal of roentgenology.
[8] K. Kihara,et al. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report , 2013, European Radiology.
[9] H. Ahmed,et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study , 2012, The Lancet. Oncology.
[10] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[11] A. Barqawi,et al. The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges , 2012, Prostate cancer.
[12] Kazutaka Saito,et al. Clinical Investigation : Genitourinary Cancer Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer , 2012 .
[13] Kazutaka Saito,et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness , 2011, European Radiology.
[14] K. Sugimura,et al. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer? , 2013, European journal of radiology.
[15] H. Ahmed,et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. , 2013, The Journal of urology.
[16] Gary Liney,et al. Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.
[17] K. Kihara,et al. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. , 2013, The Journal of urology.
[18] J. Machan,et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. , 2010, AJR. American journal of roentgenology.
[19] A. Oto,et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. , 2011, AJR. American journal of roentgenology.
[20] K. Kihara,et al. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. , 2014, European urology.
[21] Cher Heng Tan,et al. Diffusion weighted imaging in prostate cancer , 2011, European Radiology.
[22] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[23] J. O'Brien,et al. Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI , 2012, Clinical Cancer Research.
[24] Kazutaka Saito,et al. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer , 2014, Journal of magnetic resonance imaging : JMRI.